Tradestie Institutional Equity Comparison Engine

ARQT vs PVLA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ARQT Overall Edge

ARQT Captures Institutional Edge (2โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Arcutis Biotherapeutics, Inc. Common Stock (ARQT) driven by superior Valuation, Growth & Margin while PVLA counters with relative strength in Momentum & Technical. Fundamentally, ARQT trades at 25.8x Forward P/E with 6.9% operating margin (+45.1% YoY revenue) versus PVLA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ARQT sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro) against PVLA sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ARQT
ARQT 25.8x vs PVLA N/M Fwd P/E
Growth & Margin Winner ARQT
Op Margin 6.9% vs 0.0% ยท YoY +45.1% vs +0.0%
Momentum & Technical Winner PVLA
1Y +18.9% vs +80.2% ยท 52W Pos 51% vs 68%
Options & Structure Winner Tie
CONSOLIDATION (7th %ile IV) vs CONSOLIDATION (2nd %ile IV)
ARQT NASDAQ
Arcutis Biotherapeutics, Inc. Common Stock
Pharmaceutical Preparations
$27.19
-3.79% 1D
Market Cap $3.5B
1M Return -5.66%
1Y Return +18.94%
Forward P/E 25.8x
Unified AI Score
62.5 / 100 BUY
Tech 58.0 Fund 58.0 Flow 67.0 Mom 50.0
PVLA NASDAQ
Palvella Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$145.03
-4.89% 1D
Market Cap $2.2B
1M Return +20.56%
1Y Return +80.16%
Forward P/E N/M
Unified AI Score
48.2 / 100 HOLD
Tech 35.0 Fund 53.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ARQT +18.94% PVLA +80.16% Spread: +61.22 pp (PVLA Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ARQT Revenue PVLA Revenue ARQT Op. Margin PVLA Op. Margin Margin Edge
FY2018 N/A $30M N/A -113.1% PVLA
FY2019 N/A $40M N/A -62.2% PVLA
FY2020 N/A $30M N/A -115.7% PVLA
FY2021 N/A $30M N/A -165.0% PVLA
FY2022 $0M $30M -8183.0% -167.8% PVLA
FY2023 $60M $40M -404.5% -27.7% PVLA
FY2024 $200M N/A -65.3% N/A ARQT
FY2025 $380M N/A -3.3% N/A ARQT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ARQT (8) vs PVLA (2)
Institutional Metric ARQT PVLA Criterion Row Winner
Market Capitalization Scale $3.5B $2.2B Larger Scale ARQT
Trailing P/E Ratio Valuation 125.1x N/M Lower Multiple ARQT
Forward P/E Ratio Valuation 25.8x N/M Lower Multiple ARQT
Revenue Growth (YoY) Growth +45.1% +0.0% Higher Growth ARQT
Operating Margin (TTM) Profitability 6.9% 0.0% Higher Margin ARQT
Net Profit Margin Profitability 5.9% 0.0% Higher Margin ARQT
Return on Equity (ROE) Capital Efficiency 14.9% -63.4% Higher ROE ARQT
52-Week Range Position Momentum 51% ($19โ€“$35) 68% ($72โ€“$180) Stronger Trend PVLA
Beta / 30D Volatility Risk Regime 1.76ฮฒ ยท 87% Vol 1.66ฮฒ ยท 75% Vol Lower Realized Risk PVLA
Unified Institutional Score Composite Signal 62.5 / 100 (BUY) 48.2 / 100 (HOLD) Higher Composite ARQT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ARQT vs PVLA Buy Guide
ARQT CONSOLIDATION
91d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live ARQT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PVLA CONSOLIDATION
70d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live PVLA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ARQT nor PVLA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.